IL6 and type 2 diabetes mellitus: Regarding inflammatory intermediates, our study shows a slight but significant increase in TNF-α and IL-6 production in T2D patients; it is possible that the difference is not bigger because of the hypolipemiant treatments received by most of the T2D patients.